BLLN

BillionToOne, Inc.

Healthcare · Services–Medical Laboratories

$118.18Sep 29, 2026

AI confidence 73% · prior close shown (market closed)

Investment Snapshot

Strong evidence · 3 sources

Why it matters

BillionToOne, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.

Why it matters: Revenue +64% YoY in Q2 FY2026.

TrajectoryAccelerating
ExecutionMixed
RiskMedium

1 signal not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +64% YoY in Q2 FY2026
  • Guidance Maintained

Pipeline evidence · 0d ago

BLLN's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BLLN.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BLLN earnings analysis

Reported figures for BillionToOne, Inc. — research only, not investment advice.

Revenue YoY
+64.4%

Latest Intelligence

Updated

What happened recently for BillionToOne, Inc. (BLLN) — events, not interpretation.

Event
Reported Q2 2026 revenue +64% YoY.
Also
Last session September 29, 2026 at $118.18.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

BillionToOne, Inc. (BLLN)

Healthcare · Services–Medical Laboratories

Investment Snapshot above is the primary AlphaOS analysis for BillionToOne, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$6.35B
Revenue:
$108.39M

BLLN earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow BillionToOne, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.

Structured stock intelligence for companies connected to this research.